Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.

Saved in:
Bibliographic Details
Title: Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.
Authors: Shah SJ; Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: sanjiv.shah@northwestern.edu., Borlaug BA; Mayo Clinic, Rochester, MN, USA., Chung ES; The Lindner Research Center at The Christ Hospital, Cincinnati, OH, USA., Cutlip DE; Baim Clinical Research Institute, Boston, MA, USA., Debonnaire P; AZ Sint-Jan Brugge-Oostende, Bruges, Belgium., Fail PS; Cardiovascular Institute of the South, Houma, LA, USA., Gao Q; Baim Clinical Research Institute, Boston, MA, USA., Hasenfuß G; Heart Center, University Medical Center, Göttingen, Germany., Kahwash R; Ohio State University, Columbus, OH, USA., Kaye DM; Alfred Hospital, Melbourne, VIC, Australia., Litwin SE; Medical University of South Carolina and Ralph H Johnson Veterans Affairs Medical Center, Charleston, SC, USA., Lurz P; Heart Center Leipzig at University Leipzig, Leipzig, Germany., Massaro JM; Boston University, Boston, MA, USA., Mohan RC; Scripps Health, La Jolla, CA, USA., Ricciardi MJ; Northshore University Health System, Evanston, IL, USA., Solomon SD; Brigham and Women's Hospital, Boston, MA, USA., Sverdlov AL; John Hunter Hospital, University of Newcastle, New Lambton Heights, NSW, Australia., Swarup V; Arizona Heart and Rhythm Center, Phoenix, AZ, USA., van Veldhuisen DJ; University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Winkler S; BG Klinikum Unfallkrankenhaus, Berlin, Germany., Leon MB; Cardiovascular Research Foundation, New York City, NY, USA.
Corporate Authors: REDUCE LAP-HF II investigators
Source: Lancet (London, England) [Lancet] 2022 Mar 19; Vol. 399 (10330), pp. 1130-1140. Date of Electronic Publication: 2022 Feb 01.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-547X
DOI:10.1016/S0140-6736(22)00016-2